Lipodystrophy Pipeline Review, H2 2012 new report
Lipodystrophy - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Lipodystrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lipodystrophy.
View full press release